F Wewalka

1.0k citations
88 papers · 714 · h-index 14

Impact in

Papers in

    • Liver Disease Diagnosis and Treatment 17
    • Hepatitis B Virus Studies 6
    • Liver Disease and Transplantation 8
    • Hepatitis Viruses Studies and Epidemiology 4
    • Liver Diseases and Immunity 3

F Wewalka

74 papers receiving 587 citations

Peers

F Wewalka
Comparison fields: 5 of 83
  • Hepatology 166
  • Pharmacology 62
  • Epidemiology 233
  • Oncology 171
  • Pulmonary and Respiratory Medicine 192
Replace Mervin Silverberg with:
Mervin Silverberg United States
R. Stenger France
W. Michael McDonnell United States
James B. Carey United States
K G Ishak United States
F Miglio Italy
Takefumi Uchida Japan
Mohammad Wehbi United States
Jin Ding China
Andy Yu United States
F Wewalka relative to Mervin Silverberg United States Mervin Silverberg's profile →
Citations per field
00.5×4.3×
Mervin Silverberg · 1×
Citations per year

Countries citing papers authored by F Wewalka

Since Specialization
Citations

This map shows the geographic impact of F Wewalka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Wewalka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Wewalka more than expected).

Fields of papers citing papers by F Wewalka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Wewalka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Wewalka. The network helps show where F Wewalka may publish in the future.

Co-authors

The 25 scholars most cited alongside F Wewalka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F Wewalka Line = papers co-authored together F Wewalka links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1970141
2 2008104
3 201246
4 197034
5 200425
6
Adventitious connective tissue cells in the space of Disse and their relation to fibre formation.
196724
7 196223
8
Plasma amino acids in hepatic encephalopathy.
197816
9 201716
10 197016
11 197016
12
Gamma-glutamyltranspeptidase (GGTP): its relationship to other enzymes for diagnosis of liver disease.
197615
13
[The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
198014
14 198113
15 196112
16 200910
17 196210
18 195610
19 19609
20 19729

About F Wewalka

F Wewalka is a scholar working on Epidemiology, Hepatology, Surgery, Oncology and Clinical Biochemistry, having authored 88 papers that have together received 714 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (17 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Metabolism and Genetic Disorders (8 papers), Liver Disease and Transplantation (8 papers), Hepatitis B Virus Studies (6 papers), Esophageal and GI Pathology (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Hepatology (166 citations), Pharmacology (62 citations), Epidemiology (233 citations), Oncology (171 citations) and Pulmonary and Respiratory Medicine (192 citations). F Wewalka has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include C Kapral, Christine Duller, Florian Schreiber, Hugo G. Schnack, B Schobel, E Kerstan, Walther Vogel, Péter Ferenci, L Stockinger and P Knoflach. Their work appears in journals such as Journal of Molecular Medicine, Endoscopy, Vox Sanguinis, Pathobiology and European Journal of Gastroenterology & Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact